Skip to main content
. Author manuscript; available in PMC: 2022 Feb 16.
Published in final edited form as: Curr Cancer Drug Targets. 2016;16(6):489–508. doi: 10.2174/1568009616666151130214646

Table 1.

Peptides that target tumor vasculature and lymphatics.

Peptide Ligand Cellular Target Refs.
Targeting Tumor Vasculature
CDCRGDCFC (RGD-4C) αv β3, αv β5 [87, 88]
ACDCRGDCFCG αv β3, αv β5 [89]
CNGRCVSGCAGRC Aminopeptidase N [90]
TAASGVRSMH, LTLRWVGLMS NG2 proteoglycan [91]
CGSLVRC, CGLSDSC Vasculature of various tumors [28]
NRSLKRISNKRIRRK, LRIKRKRRKRKKTRK, NRSTHI IC-12 rat tracheal tumor [92]
SMSIARL, VSFLEYR Mice prostate [93]
CPGPEGAGC Aminopeptidase P [94]
ATWLPPR VEGF [95]
RRKRRR VEGF [96]
ASSSYPLIHWRPWAR VEGF [97]
CTTHWGFTLC Gelatinase [98]
Ciso DGRCG αv β3, αv β5 [99]
cyclo[(3R,6S)DKP-isoDGR], cyclo[(3S,6R)DKP-isoDGR] αv β3, αv β5 [100]
CTPSPFSHC Unknown [101]
CSRPRRSEC, CGKRK, CDTRL Unknown [102]
CKAAKNK, CKGAKAR,
CRGRRST
First two unknown
Last one PDGF-β
[103, 104]
CRGDK/RGPD/EC (iRGD) αvβ3, αvβ5, neuropilin-1 [79, 80]
CPRECESIC Aminopeptidase A [105]
CGNSNPKSC Unknown [106]
SVSVGMKPSPRP Unknown [107]
IFLLWQR Annexin 1 [108]
Targeting Tumor Lymphatics
CGNKRTRGC (LyP-1) p32/gC1qR [72, 109, 110]
CNRRTKAGC, CLSDGKRKC, CREAGRKAC, CAGRRSAYC [110, 111]